Assessment of stigma related to visible skin diseases: a systematic review and evaluation of patient-reported outcome measures.
Journal
Journal of the European Academy of Dermatology and Venereology : JEADV
ISSN: 1468-3083
Titre abrégé: J Eur Acad Dermatol Venereol
Pays: England
ID NLM: 9216037
Informations de publication
Date de publication:
Apr 2022
Apr 2022
Historique:
received:
26
07
2021
accepted:
03
11
2021
pubmed:
25
11
2021
medline:
17
3
2022
entrez:
24
11
2021
Statut:
ppublish
Résumé
Misconceptions about visible skin diseases are widespread, and patients often face discrimination and stigmatization due to their condition. The associated negative health and psychosocial consequences of stigmatization in skin diseases have prompted an increase in research activity in recent times, resulting in a wide variety of assessment measures. This study aimed at aggregating and evaluating evidence of psychometric properties and methodological quality of published measures to assess stigma in visible skin diseases. Studies assessing stigmatization in visible skin diseases were searched in four databases (Medline, PsycINFO, Web of Science and Embase) until February 2021. The review followed PRISMA guidelines. Papers regarding development and/or validation of measures were identified by two independent researchers. Inclusion criteria were defined as follows: (i) quantitative studies in (ii) populations with skin diseases using (iii) questionnaires explicitly assessing (iv) perceived or public stigmatization or discrimination available in (iv) English or German language. The COnsensus-based Standards of health Measurement INstruments (COSMIN) checklist was used to evaluate their psychometric properties and risk of bias. 35 studies using 21 instruments were identified. Twenty instruments focused on assessing the perceived reality of those affected by visible skin diseases, while public stigma was only assessed by two instruments. Twelve scales could be recommended for use, while nine instruments had the potential to be recommended after further studies have assessed their quality. Some limitations are to be noted. Only studies in English and German were included. Research on self-constructed instruments can lead to new validated instruments, but they were not included in the review at this point. Several validated instruments could be recommended for use. Future research is needed regarding the assessment of stigma across different visible skin diseases, in children and adolescents, and in the general public.
Types de publication
Journal Article
Review
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
499-525Subventions
Organisme : Bundesministerium für Gesundheit
ID : ZMVI1-2517FSB808
Informations de copyright
© 2021 The Authors. Journal of the European Academy of Dermatology and Venereology published by John Wiley & Sons Ltd on behalf of European Academy of Dermatology and Venereology.
Références
Mehrmal S, Uppal P, Giesey RL, Delost GR. Identifying the prevalence and disability-adjusted life years of the most common dermatoses worldwide. J Am Acad Dermatol 2020; 82: 258-259.
Karimkhani C, Dellavalle RP, Coffeng LE et al. Global skin disease morbidity and mortality: an update from the global burden of disease study 2013. JAMA Dermatol 2017; 153: 406-412.
Harlow D, Poyner T, Finlay AY, Dykes PJ. Impaired quality of life of adults with skin disease in primary care. Br J Dermatol 2000; 143: 979-982.
Dalgard FJ, Gieler U, Tomas-Aragones L et al. The psychological burden of skin diseases: a cross-sectional multicenter study among dermatological out-patients in 13 European countries. J Invest Dermatol 2015; 135: 984-991.
Dimitrov D, Szepietowski JC. Stigmatization in dermatology with a special focus on psoriatic patients. Postepy Hig Med Dosw (Online) 2017; 71: 1115-1122.
Stigma GE. Notes on the Stigma: Notes on the Management of Spoiled Identity. Prentice Hall, Englewood-Cliffs and NJ. 1963.
Link BG, Phelan JC. Conceptualizing stigma. Annu. Rev. Sociol 2001; 27: 363-385.
Corrigan PW, Larson JE, Kuwabara SA. Social psychology of the stigma of mental illness: Public and self-stigma models. In Maddux JE, Tangney JP, eds. Social Psychological Foundations of Clinical Psychology, The Guilford Press, New York, NY, 2010: 51-68.
Scambler G. Health-related stigma. Sociol Health Illn 2009; 31: 441-455.
Boyle MP. Enacted stigma and felt stigma experienced by adults who stutter. J Commun Disord 2018; 73: 50-61.
Bos AER, Pryor JB, Reeder GD, Stutterheim SE. Stigma: advances in theory and research. Basic Appl Soc Psychol. 2013; 35: 1-9.
Herek GM, Gillis JR, Cogan JC. Internalized stigma among sexual minority adults: Insights from a social psychological perspective. J Couns Psychol 2009; 56: 32-43.
Livingston JD, Boyd JE. Correlates and consequences of internalized stigma for people living with mental illness: a systematic review and meta-analysis. Soc Sci Med 2010; 71: 2150-2161.
Molina Y, Choi SW, Cella D, Rao D. The stigma scale for chronic illnesses 8-item version (SSCI-8): development, validation and use across neurological conditions. Int J Behav Med 2013; 20: 450-460.
Quinn DM, Earnshaw VA. Concealable stigmatized identities and psychological well-being. Soc Personal Psychol Compass 2013; 7: 40-51.
Germain N, Augustin M, François C et al. Stigma in visible skin diseases - a literature review and development of a conceptual model. J Eur Acad Dermatol Venereol 2021; 35: 1493-1504.
Halioua B, Sid-Mohand D, Roussel ME et al. Extent of misconceptions, negative prejudices and discriminatory behaviour to psoriasis patients in France. J Eur Acad Dermatol Venereol 2016; 30: 650-654.
Sommer R, Mrowietz U, Radtke MA et al. What is psoriasis? - Perception and assessment of psoriasis among the German population. J Deuts Dermatol Ges 2018; 16: 703-710.
Wu JH, Cohen BA. The stigma of skin disease. Curr Opin Pediatr 2019; 31: 509-514.
Corrigan PW, Larson JE, Rüsch N. Self-stigma and the "why try" effect: impact on life goals and evidence-based practices. World Psychiatry 2009; 8: 75-81.
Alpsoy E, Polat M, FettahlıoGlu-Karaman B et al. Internalized stigma in psoriasis: a multicenter study. J Dermatol 2017; 44: 885-891.
Łakuta P, Marcinkiewicz K, Bergler-Czop B, Brzezińska-Wcisło L. The relationship between psoriasis and depression: a multiple mediation model. Body Image 2016; 19: 126-132.
Łakuta P, Marcinkiewicz K, Bergler-Czop B, Brzezińska-Wcisło L. How does stigma affect people with psoriasis? Postepy Dermatol Alergol 2017; 34: 36-41.
Elman SA, Merola JF, Armstrong AW et al. The international dermatology outcome measures (IDEOM) initiative: a review and update. J Drugs Dermatol 2017; 16: 119-124.
World Health Organization (WHO) Global report on psoriasis. [WWW document]. URL https://apps.who.int/iris/handle/10665/204417 (last accessed: 26 July 2021).
World Health Organization (WHO). Resolution on psoriasis [WWW document]. 2014. URL https://apps.who.int/gb/ebwha/pdf_files/WHA67/A67_R9-en.pdf (last accessed: 26 July 2021).
Dimitrov D, Szepietowski JC. Instruments to assess stigmatization in dermatology. Postepy Hig Med Dosw (Online) 2017; 71: 901-905.
Mokkink LB, Prinsen CAC, Patrick DL et al. COSMIN methodology for systematic reviews of Patient-Reported Outcome Measures (PROMs): User Manual [WWW document], 2018: URL https://www.cosmin.nl/tools/guideline-conducting-systematic-review-outcome-measures/?portfolioCats=19 (last accessed: 19 February 2021).
Mokkink LB, de Vet HCW, Prinsen CAC et al. COSMIN risk of bias checklist for systematic reviews of patient-reported outcome measures. Qual Life Res 2018; 27: 1171-1179.
Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J. Clin. Epidemiol 2009; 62: 1006-1012.
Terwee CB, Prinsen CAC, Chiarotto A et al. COSMIN methodology for evaluating the content validity of patient-reported outcome measures: a Delphi study. Qual Life Res 2018; 27: 1159-1170.
Baars RM, Atherton CI, Koopman HM et al. The European DISABKIDS project: development of seven condition-specific modules to measure health related quality of life in children and adolescents. Health Qual Life Outcomes 2005; 3: 70.
Peters RMH, Dadun D, Van Brakel WH et al. The cultural validation of two scales to assess social stigma in leprosy. PLoS Negl Trop Dis 2014; 8: e3274.
Rensen C, Bandyopadhyay S, Gopal PK, van Brakel WH. Measuring leprosy-related stigma - a pilot study to validate a toolkit of instruments. Disabil Rehabil 2011; 33: 711-719.
Ginsburg IH, Link BG. Feelings of stigmatization in patients with psoriasis. J Am Acad Dermatol 1989; 20: 53-63.
Fischer TW, Schmidt S, Strauss B, Elsner P. Hairdex: a tool for evaluation of disease-specific quality of life in patients with hair diseases. Hautarzt 2001; 52: 219-227.
Evers AWM, Duller P, van de Kerkhof PCM et al. The impact of chronic skin disease on daily Life (ISDL): a generic and dermatology-specific health instrument. Br J Dermatol 2008; 158: 101-108.
Govindharaj P, Srinivasan S, Darlong J et al. A new instrument to measure leprosy internalised stigma: the leprosy internalised stigma scale (LISS). LEPROSY 2018; 89: 242-255.
Potter LP, Mathias SD, Raut M et al. The OnyCOE-t questionnaire: responsiveness and clinical meaningfulness of a patient-reported outcomes questionnaire for toenail onychomycosis. Health Qual Life Outcomes 2006; 4: 50.
van Brakel WH, Anderson AM, Mutatkar RK et al. The participation scale: measuring a key concept in public health. Disabil Rehabil 2006; 28: 193-203.
Stevelink SAM, Hoekstra T, Nardi SMT et al. Development and structural validation of a shortened version of the participation scale. Disabil Rehabil 2012; 34: 1596-1607.
Lawrence JW, Fauerbach JA, Heinberg LJ et al. The reliability and validity of the Perceived Stigmatization Questionnaire (PSQ) and the Social Comfort Questionnaire (SCQ) among an adult burn survivor sample. Psychol Assess 2006; 18: 106-111.
Franklin H, Tora A, Deribe K et al. Development of a scale to measure stigma related to podoconiosis in Southern Ethiopia. BMC Public Health 2013; 13: 298.
Dadun D, Peters RMHvan Brakel WH et al. Cultural validation of a new instrument to measure leprosy-related stigma: the SARI Stigma Scale. LEPROSY 2017; 88: 23-42.
Lawrence JW, Heinberg LJ, Roca R et al. Development and validation of the satisfaction with appearance scale: assessing body image among burn-injured patients. Psychol Assess 1998; 10: 64-70.
Heinberg LJ, Kudel I, White B et al. Assessing body image in patients with systemic sclerosis (scleroderma): validation of the adapted Satisfaction with appearance scale. Body Image 2007; 4: 79-86.
Schmid-Ott G, Jäger B, Künsebeck HW et al. Entwicklung des „Fragebogens zum Erleben von Haut-beschwerden“ (FEH): Faktorenanalyse und Untersuchung von Prädiktoren für das Krankheitserleben von Psoriasis-Patienten. Z Klin Psychol Psychiat Psychothe 1998; 46: 330-343.
Schmid-Ott G, Burchard R, Niederauer HH et al. Stigmatisierungsgefühl und Lebensqualität bei patienten mit psoriasis und neurodermitis. Hautarzt 2003; 54: 852-857.
Deon KC, Santos DMdSSd, Bullinger M, Santos CBD. Preliminary psycometric assessment of the Brazilian version of the DISABKIDS Atopic Dermatitis Module. Rev Saude Publica 2011; 45: 1072-1078.
da Rocha F, Morgado F, Xavier K et al. Psychometric assessment of the EMIC Stigma Scale for Brazilians affected by leprosy. PLoS One 2020; 15: e0239186.
Dimitrov D, Matusiak Ł, Evers A et al. Arabic language skin-related stigmatization instruments: translation and validation process. Adv Clin Exp Med 2019; 28: 825-832.
Wittkowski A, Richards HL, Williams J et al. An examination of the psychometric properties and factor structure of the feelings of stigmatization questionnaire. J Clin Psychol Med Settings 2007; 14: 248-257.
de Zeeuw J, Douwstra M, Omansen TF et al. Psychometric properties of the participation scale among former buruli ulcer patients in Ghana and Benin. PLoS Negl Trop Dis 2014; 8: e3254.
Freitas NDO, Forero CG, Caltran MP et al. Validation of the perceived stigmatization questionnaire for brazilian adult burn patients. PLoS One 2018; 13: e0190747.
Lawrence JW, Rosenberg L, Rimmer RB et al. Perceived stigmatization and social comfort: validating the constructs and their measurement among pediatric burn survivors. Rehabil Psychol 2010; 55: 360-371.
Müller A, Smits D, Claes L et al. Validation of the German version of the perceived stigmatization questionnaire/social comfort questionnaire in adult burn survivors. Burns 2016; 42: 790-796.
Freitas NO, Forero CG, Alonso J et al. Cross-cultural adaptation and validation of the Social Comfort Questionnaire for Brazilian adult survivors of burns. Qual Life Res 2017; 26: 205-211.
Schmid-Ott G, Kuensebeck HW, Jaeger B et al. Validity study for the stigmatization experience in atopic dermatitis and psoriatic patients. Acta Derm Venereol 1999; 79: 443-447.
Müller H, Brockow T, Franke A et al. Construct validity of the questionnaire on experience with skin complaints (Short Form). Eur J Psychol Assess 2007; 23: 176-184.
Franklin H, Tora A, Deribe K, Reda A, Davey G. Development of a scale to measure stigma. BMC Public Health 2013; 13: 1-9.
Lawrence JW, Heinberg LJ, Roca R, Munster A, Spence R, Fauerbach JA. Development and validation of the satisfaction with appearance scale: assessing body image among burn-injured patients. Psychol Assess 1998; 10: 64-70.
Schmid-Ott G, Jäger B, Künsebeck HW, Ott R, Wedderer K, Lamprecht F. Entwicklung des „Fragebogens zum Erleben von Haut-beschwerden“ (FEH): Faktorenanalyse und Untersuchung von Prädiktoren für das Krankheitserleben von Psoriasis-Patienten. Z Klin Psychol Psychiat Psychothe 1998.
Seth D, Cheldize K, Brown D, Freeman EF. Global burden of skin disease: inequities and innovations. Curr Dermatol Rep 2017; 6: 204-210.
Misra S, Jackson VW, Chong J et al. Systematic review of cultural aspects of stigma and mental illness among racial and ethnic minority groups in the United States: implications for interventions. Am J Community Psychol 2021; 68: 486-512.
Sommer R, Topp J, Mrowietz U et al. Perception and determinants of stigmatization of people with psoriasis in the German population. J Eur Acad Dermatol Venereol 2020; 34: 2846-2855.
Mukolo A, Heflinger CA, Wallston KA. The stigma of childhood mental disorders: a conceptual framework. J Am Acad Child Adolesc Psychiatry 2010; 49: 92-198.
Pearl RL, Wan MT, Takeshita J, Gelfand JM. Stigmatizing attitudes toward persons with psoriasis among laypersons and medical students. J Am Acad Dermatol 2019; 80: 1556-1563.
Augustin M, Mrowietz U, Luck-Sikorski C et al. Translating the WHA resolution in a member state: towards a German programme on 'Destigmatization' for individuals with visible chronic skin diseases. J Eur Acad Dermatol Venereol 2019; 33: 2202-2208.